Dr Reddys Laboratories (RDY) Change in Inventory (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Change in Inventory of -$76.7 million for Q2 2026, down 228.53% on a QoQ basis from -$23.3 million in Q3 2025, and down 6.71% year-over-year from -$82.2 million in Q2 2025.
Analysis
Dr Reddys Laboratories (RDY) Change in Inventory (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories has reported Change in Inventory for 17 years, with the latest figure at -$76.7 million in Q2 2026.
- On a quarterly basis, Change in Inventory fell 6.71% year-over-year to -$76.7 million in Q2 2026; TTM through Jun 2026 was -$231.7 million, a 8.94% increase from a year earlier, with the FY2026 full-year figure at -$92.0 million, up 38.26% from the prior year.
- Change in Inventory was -$76.7 million for Q2 2026 at Dr Reddys Laboratories, down from -$23.3 million in the prior quarter.
- The five-year high for Change in Inventory was $15.9 million in Q3 2022, with the low at -$188.5 million in Q1 2022.
- Average Change in Inventory over 5 years is -$53.7 million, with a median of -$56.7 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: Change in Inventory jumped 99.22% in 2023, then plunged 3092.11% in 2024.
- Over 5 years, Change in Inventory stood at -$20.0 million in 2022, then tumbled by 212.26% to -$62.5 million in 2023, then climbed by 4.31% to -$59.8 million in 2024, then jumped by 60.96% to -$23.3 million in 2025, then slumped by 228.53% to -$76.7 million in 2026.
- The last three Change in Inventory figures came in at -$76.7 million (Q2 2026), -$23.3 million (Q3 2025), and -$71.9 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.55 Bn | 38.89 Bn | 2.15 Bn | -59.00 Mn |
| 2 | Viatris | 19.15 Bn | 18.26 Bn | 1.46 Bn | 99.50 Mn |
| 3 | Dr Reddys Laboratories | 9.87 Bn | 9.70 Bn | 396.53 Mn | -76.69 Mn |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.32 Bn | 334.51 Mn | 69.19 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn | 22.00 Mn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | -403,000.00 |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | -305,000.00 |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | 9.88 Mn |
| 9 | Fennec Pharmaceuticals | 401.76 Mn | 360.51 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -76.69 Mn |
| Sep 30, 2025 | -23.34 Mn |
| Jun 30, 2025 | -71.86 Mn |
| Sep 30, 2024 | -59.79 Mn |
| Jun 30, 2024 | -75.80 Mn |
| Mar 31, 2024 | -46.99 Mn |
| Dec 31, 2023 | -62.49 Mn |
| Sep 30, 2023 | -56.88 Mn |
| Jun 30, 2023 | -56.45 Mn |
| Mar 31, 2023 | -1.47 Mn |
| Dec 31, 2022 | -20.01 Mn |
| Sep 30, 2022 | 15.87 Mn |
| Jun 30, 2022 | -27.95 Mn |
| Mar 31, 2022 | -188.51 Mn |
| Dec 31, 2021 | 114.13 Mn |
| Sep 30, 2021 | 14.45 Mn |
| Jun 30, 2021 | -72.68 Mn |
| Mar 31, 2021 | -49.72 Mn |
| Dec 31, 2020 | -42.99 Mn |
| Sep 30, 2020 | -26.22 Mn |